Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on September 19, 2025
AI Week New York 2025 Launches to Celebrate Citywide AI Innovation — By Pulse NYC, Oct 6–12
AI Week New York 2025 presented by Pulse NYC spotlights AI innovation with a citywide festival of events, panels, demos and meetups — Oct 6–12. NEW YORK, NY, UNITED STATES, September 19, 2025 /EINPresswire.com/ -- Pulse NYC is proud to announce AI Week …
MTA Buses & Semi-Truck Risks in NYC: Sniper Law Calls for Targeted Safety Reforms
Sniper Law urges NYC safety reforms as MTA bus crashes rise and large-truck collisions cause hundreds of injuries and deaths, despite overall fatality declines. NEW YORK, NY, UNITED STATES, September 19, 2025 /EINPresswire.com/ -- Sniper Law is calling …
Saxena White P.A. Files Securities Fraud Class Action Against Sina Corporation and Certain of Its Executives
BOCA RATON, Fla., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Southern District of New York against Sina Corporation (“Sina” or the …
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction
LOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and …
CEA Industries Board Authorizes $250 Million Stock Buyback Program
New York, Sept. 19, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or the “Company”), the world’s leading corporate holder of BNB and prominent industry advocate of BNB adoption, today announced that its Board of Directors has …
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction
LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen …
RedCloud to Present AI-Native Vision to Digitize and Transform Global Trade
LONDON, Sept. 19, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”) the technology company behind the RedAI trading platform used by Fast Moving Consumer Goods (FMCG) Manufacturers, Distributors and Retailers, today …
SPPI DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important September 24 Deadline in Securities Class Action – SPPI
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the …
Sound Community Bancorp, Inc. Announces Executive Leadership Transition
SEATTLE, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Sound Financial Bancorp, Inc (NASDAQ:SFBC), (the “Company”) the holding company for Sound Community Bank (the “Bank”), today announced that, effective October 1, 2025, it has unanimously …
ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Fly-E Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYE
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fly-E Group, Inc. (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), …
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …